Literature DB >> 7963631

Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections.

T Ejlertsen1, E Thisted, F Ebbesen, B Olesen, J Renneberg.   

Abstract

The colonisation rate of Branhamella catarrhalis in patients from 0 to 45 years of age was examined. Of 561 women admitted to hospital in labour, 6 (1%) carried B. catarrhalis in their throats but none carried the organism in their vaginas. None of 534 newborn babies became colonised at birth or during their 5 days' stay in hospital. Neither were 102 neonates < 1 month of age in hospital colonised. The maximum colonisation rate during childhood was observed in children 1-48 months of age with 143 of 266 (54%) children colonised. Among children 4-15 years of age, four of 57 (7%) children with healthy respiratory tracts were colonised. Significantly more children with upper or lower respiratory tract infections (RTI) were colonised (68%) than were children without such infections (36%), (P < 0.001). After recovery from RTI, the isolation rate in the RTI group fell to that of the non-RTI group. A seasonal variation in prevalence was not observed. Of all the strains of B. catarrhalis isolated, 84% produced beta-lactamase.

Entities:  

Mesh:

Year:  1994        PMID: 7963631     DOI: 10.1016/s0163-4453(94)94979-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  20 in total

1.  Gram-negative Diplococcal Respiratory Infections.

Authors:  Nargis Naheed; Maqsood Alam; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

Review 2.  Antibiotics for acute laryngitis in adults.

Authors:  Ludovic Reveiz; Andrés Felipe Cardona
Journal:  Cochrane Database Syst Rev       Date:  2015-05-23

3.  Cold shock response of the UspA1 outer membrane adhesin of Moraxella catarrhalis.

Authors:  Nadja Heiniger; Rolf Troller; Patricia Stutzmann Meier; Christoph Aebi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.

Authors:  X X Gu; J Chen; S J Barenkamp; J B Robbins; C M Tsai; D J Lim; J Battey
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 5.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

6.  Moraxella catarrhalis bacteraemia and prosthetic valve endocarditis.

Authors:  Lokesh Shahani; Shahriar Tavakoli Tabasi
Journal:  BMJ Case Rep       Date:  2015-10-23

Review 7.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

8.  Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease.

Authors:  Grant A Mackenzie; Amanda J Leach; Jonathan R Carapetis; Janelle Fisher; Peter S Morris
Journal:  BMC Infect Dis       Date:  2010-10-23       Impact factor: 3.090

9.  The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.

Authors:  Taketo Otsuka; Charmaine Kirkham; Aimee Brauer; Mary Koszelak-Rosenblum; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

10.  Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults.

Authors:  Patricia Stutzmann Meier; Nadja Heiniger; Rolf Troller; Christoph Aebi
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.